Form 4: Alignment Healthcare President Sells $2.6M in Stock

Alignment Healthcare's President, Dawn C. Maroney, sold 130,000 shares of common stock for approximately $2.6 million under a pre-arranged 10b5-1 trading plan.

Summary

• Dawn C. Maroney, President of Alignment Healthcare, Inc. (ALHC), reported the sale of 130,000 shares of common stock.
• The sales were executed under a Rule 10b5-1 trading plan adopted on May 22, 2025.
• On December 12, 2025, 16,681 shares were sold at a weighted-average price of $20.0204 per share, with prices ranging from $20.00 to $20.04.
• On December 15, 2025, an additional 113,319 shares were sold at a weighted-average price of $20.0068 per share, with prices ranging from $19.37 to $20.28.
• Following these transactions, Ms. Maroney beneficially owns 1,667,237 shares of Alignment Healthcare common stock directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While an insider sale reduces direct ownership, the execution under a pre-arranged 10b5-1 plan suggests a planned financial strategy for diversification or liquidity, rather than a bearish outlook on the company's immediate prospects.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned liquidity event rather than a reaction to new, non-public negative information.

Negatives

• The President of Alignment Healthcare, Dawn C. Maroney, reduced her direct beneficial ownership by 130,000 shares, which could be interpreted as a decrease in insider confidence, although mitigated by the 10b5-1 plan.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends. It reflects a routine disclosure for executive stock sales in the healthcare sector.

Stakeholder Impact

• Shareholders: The sale by a key executive could be viewed with slight caution, but the 10b5-1 plan mitigates concerns about a lack of confidence in the company's future. It represents a reduction in direct insider alignment.

Key Dates

Recommendation

The filing reports a pre-scheduled insider stock sale under a 10b5-1 plan. Such transactions are typically for personal financial planning and do not inherently signal a change in the company's fundamental outlook. While a reduction in insider ownership is noted, it's not indicative of a strong buy or sell signal based solely on this filing. Investors should continue to monitor company performance and other disclosures.

Keywords

Alignment Healthcare, ALHC, Insider Sale, Form 4, 10b5-1 Plan, Stock Transaction, Executive Compensation, Healthcare